Your browser doesn't support javascript.
loading
Evolution of Lantibiotic Salivaricins: New Weapons to Fight Infectious Diseases.
Barbour, Abdelahhad; Wescombe, Philip; Smith, Leif.
Afiliação
  • Barbour A; Faculty of Dentistry, University of Toronto, Toronto, ON, Canada. Electronic address: abdelahhad.barbour@utoronto.ca.
  • Wescombe P; Yili Innovation Center Oceania, Lincoln University, Christchurch, New Zealand.
  • Smith L; Department of Biology, College of Science, Texas A&M University, College Station, TX, USA.
Trends Microbiol ; 28(7): 578-593, 2020 07.
Article em En | MEDLINE | ID: mdl-32544444
ABSTRACT
Lantibiotic salivaricins are polycyclic peptides containing lanthionine and/or ß-methyllanthionine residues produced by certain strains of Streptococcus salivarius, which almost exclusively reside in the human oral cavity. The importance of these molecules stems from their antimicrobial activity towards relevant oral pathogens which has so far been applied through the development of salivaricin-producing probiotic strains. However, salivaricins may also prove to be of great value in the development of new and novel antibacterial therapies in this era of emerging antibiotic resistance. In this review, we describe the biosynthesis, antimicrobial activity, structure, and mode of action of the lantibiotic salivaricins characterized to date. Moreover, we also provide an expert opinion and suggestions for future development of this important field of microbiology.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Bacteriocinas / Streptococcus salivarius / Antibacterianos Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Bacteriocinas / Streptococcus salivarius / Antibacterianos Idioma: En Ano de publicação: 2020 Tipo de documento: Article